C07D251/52

Use of 2,4-dihalo-6-substituted-1,3,5-triazines and derivative thereof as condensation, cross-linking, tanning, grafting and curing agents
11104767 · 2021-08-31 · ·

Use of 2,4-dihalo-6-substituted-1,3,5-triazines as condensing, cross-linking, tanning, grafting, curing agents for the production of amides, esters, thioesters, and stabilized collagen and leather, CMC (carboxymethyl cellulose), synthetic and natural polymers. The process enables to obtain non-toxic and totally free of heavy metals products characterized by Tg values between 80° C. and 100° C.

POLYETHER GROUP-CONTAINING COMPOUND

A polyether group-containing compound of the formula (I). In each of the compound of the formula (I), one or two R— are represented by (Rf—X.sup.f1-PE-X.sup.f2).sub.α—X.sup.1—, and one or two R— are represented by R.sup.Si—. The symbols are as defined in the description.

##STR00001##

POLYETHER GROUP-CONTAINING COMPOUND

A polyether group-containing compound of the formula (I). In each of the compound of the formula (I), one or two R— are represented by (Rf—X.sup.f1-PE-X.sup.f2).sub.α—X.sup.1—, and one or two R— are represented by R.sup.Si—. The symbols are as defined in the description.

##STR00001##

MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME
20200392406 · 2020-12-17 ·

Disclosed are compounds represented by structural formula

##STR00001## methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.

MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME
20200392406 · 2020-12-17 ·

Disclosed are compounds represented by structural formula

##STR00001## methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.

Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby

A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.

Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby

A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.

COMPOSITION, FILM, AND PRODUCTION METHOD OF PATTERNED SUBSTRATE

A composition contains: a compound including at least one group selected from the group consisting of a group represented by formula (1-1), a group represented by formula (1-2), and a group represented by formula (1-3); and a solvent. In formulae (1-1) to (1-3), * and ** each denote a site bonding to a part other than the group represented by the formulae (1-1) to (1-3) in the compound; and a and b are each independently an integer of 0 to 3. In a case in which a is 0, b is no less than 1, and in a case in which a is no less than 1, b is 0.

##STR00001##

METHODS OF TREATMENT OF MALIGNANCIES
20200268726 · 2020-08-27 ·

Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.

IDH1 INHIBITORS FOR THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS

Provided are methods and compositions for treating cancers in patients carrying an IDH1 mutation or IDH2 mutation.